A new anti-viral, anti-inflammatory drug against coronavirus might be soon offered to patients all over the world by Israeli pharmaceutical company RedHill.
The treatment, based on a chemical compound called Opaganib, has already shown very promising result in compassionate use carried out a the Shaarei Zedek Medical Center in Jerusalem, as Gilead Raday, RedHill's Chief Operating Officer, told The Jerusalem Post.
